TGFB1 and cancer: Exposure to TGF-β ligand decreases the ability of activated NK cells to kill cancer cells ex vivo, while inhibition of TGF-β signaling in the tumor microenvironment preserves the function of highly activated, in vitro expanded NK cells in CRC in vivo [96].